Mutant-Selective Allosteric EGFR Degraders are Effective Against a Broad Range of Drug-Resistant Mutations.
作者： Jaebong Jang , Ciric To , Dries J. H. De Clercq , Eunyoung Park , Charles M. Ponthier
关键词:
摘要: … or DDC-01-163 alone or in combination with two constant doses of DDC-01-163 and … Our results showed that the addition of both 0.01 μm and 0.1 μm of DDC-01-163 shifted the …
sci-hub.st 参考文章(42)
Daniel P Bondeson, Alina Mares, Ian E D Smith, Eunhwa Ko, Sebastien Campos, Afjal H Miah, Katie E Mulholland, Natasha Routly, Dennis L Buckley, Jeffrey L Gustafson, Nico Zinn, Paola Grandi, Satoko Shimamura, Giovanna Bergamini, Maria Faelth-Savitski, Marcus Bantscheff, Carly Cox, Deborah A Gordon, Ryan R Willard, John J Flanagan, Linda N Casillas, Bartholomew J Votta, Willem den Besten, Kristoffer Famm, Laurens Kruidenier, Paul S Carter, John D Harling, Ian Churcher, Craig M Crews, Catalytic in vivo protein knockdown by small-molecule PROTACs Nature Chemical Biology. ,vol. 11, pp. 611- 617 ,(2015) , 10.1038/NCHEMBIO.1858
Kenneth S Thress, Cloud P Paweletz, Enriqueta Felip, Byoung Chul Cho, Daniel Stetson, Brian Dougherty, Zhongwu Lai, Aleksandra Markovets, Ana Vivancos, Yanan Kuang, Dalia Ercan, Sarah E Matthews, Mireille Cantarini, J Carl Barrett, Pasi A Jänne, Geoffrey R Oxnard, Acquired EGFR C797S mutation mediates resistance to AZD9291 in non–small cell lung cancer harboring EGFR T790M Nature Medicine. ,vol. 21, pp. 560- 562 ,(2015) , 10.1038/NM.3854
Michael Juchum, Marcel Günther, Stefan A. Laufer, Fighting cancer drug resistance: Opportunities and challenges for mutation-specific EGFR inhibitors. Drug Resistance Updates. ,vol. 20, pp. 12- 28 ,(2015) , 10.1016/J.DRUP.2015.05.002
G. E. Winter, D. L. Buckley, J. Paulk, J. M. Roberts, A. Souza, S. Dhe-Paganon, J. E. Bradner, Phthalimide conjugation as a strategy for in vivo target protein degradation Science. ,vol. 348, pp. 1376- 1381 ,(2015) , 10.1126/SCIENCE.AAB1433
Helena A. Yu, Shaozhou K. Tian, Alexander E. Drilon, Laetitia Borsu, Gregory J. Riely, Maria E. Arcila, Marc Ladanyi, Acquired Resistance of EGFR-Mutant Lung Cancer to a T790M-Specific EGFR Inhibitor: Emergence of a Third Mutation (C797S) in the EGFR Tyrosine Kinase Domain JAMA Oncology. ,vol. 1, pp. 982- 984 ,(2015) , 10.1001/JAMAONCOL.2015.1066
Takayuki Kosaka, Yasushi Yatabe, Hideki Endoh, Kimihide Yoshida, Toyoaki Hida, Masahiro Tsuboi, Hirohito Tada, Hiroyuki Kuwano, Tetsuya Mitsudomi, Analysis of Epidermal Growth Factor Receptor Gene Mutation in Patients with Non–Small Cell Lung Cancer and Acquired Resistance to Gefitinib Clinical Cancer Research. ,vol. 12, pp. 5764- 5769 ,(2006) , 10.1158/1078-0432.CCR-06-0714
M. Raymond V. Finlay, Mark Anderton, Susan Ashton, Peter Ballard, Paul A. Bethel, Matthew R. Box, Robert H. Bradbury, Simon J. Brown, Sam Butterworth, Andrew Campbell, Christopher Chorley, Nicola Colclough, Darren A. E. Cross, Gordon S. Currie, Matthew Grist, Lorraine Hassall, George B. Hill, Daniel James, Michael James, Paul Kemmitt, Teresa Klinowska, Gillian Lamont, Scott G. Lamont, Nathaniel Martin, Heather L. McFarland, Martine J. Mellor, Jonathon P. Orme, David Perkins, Paula Perkins, Graham Richmond, Peter Smith, Richard A. Ward, Michael J. Waring, David Whittaker, Stuart Wells, Gail L. Wrigley, Discovery of a potent and selective EGFR inhibitor (AZD9291) of both sensitizing and T790M resistance mutations that spares the wild type form of the receptor Journal of Medicinal Chemistry. ,vol. 57, pp. 8249- 8267 ,(2014) , 10.1021/JM500973A
Tomoaki Tanaka, Masaru Matsuoka, Akihisa Sutani, Akihiko Gemma, Makoto Maemondo, Akira Inoue, Shoji Okinaga, Makoto Nagashima, Satoshi Oizumi, Kazutsugu Uematsu, Yoshiaki Nagai, Gaku Moriyama, Hitoshi Miyazawa, Kenji Ikebuchi, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara, Frequency of and variables associated with the EGFR mutation and its subtypes International Journal of Cancer. ,vol. 126, pp. 651- 655 ,(2010) , 10.1002/IJC.24746
Thomas J. Lynch, Daphne W. Bell, Raffaella Sordella, Sarada Gurubhagavatula, Ross A. Okimoto, Brian W. Brannigan, Patricia L. Harris, Sara M. Haserlat, Jeffrey G. Supko, Frank G. Haluska, David N. Louis, David C. Christiani, Jeff Settleman, Daniel A. Haber, Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib The New England Journal of Medicine. ,vol. 350, pp. 2129- 2139 ,(2004) , 10.1056/NEJMOA040938
Yoon-La Choi, Jong-Mu Sun, Juhee Cho, Sanjay Rampal, Joungho Han, Bhash Parasuraman, Eliseo Guallar, Genehee Lee, Jeeyun Lee, Young Mog Shim, EGFR mutation testing in patients with advanced non-small cell lung cancer: a comprehensive evaluation of real-world practice in an East Asian tertiary hospital. PLOS ONE. ,vol. 8, ,(2013) , 10.1371/JOURNAL.PONE.0056011